Empagliflozin add-on to Insulin in Type 1 Diabetes Mellitus Over 28 Days
Clinical trial NCT01969747 · COMPLETED
Trial details
- NCT number
- NCT01969747
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-04-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.